Tsai, Yun-JuYun-JuTsaiYUNG-TSU CHOCHIA-YU CHU2022-09-192022-09-192022-071175-0561https://scholars.lib.ntu.edu.tw/handle/123456789/621160Rituximab is a potential initial adjuvant therapy for bullous pemphigoid, yet clinical experience is scarce.enPROGNOSTIC-FACTORSEUROPEAN ACADEMYMORTALITYASSOCIATIONDERMATOLOGYINFECTIONSMANAGEMENTDIAGNOSISDEATHRISK[SDGs]SDG3Clinical Effectiveness and Safety of Initial Combination Therapy with Corticosteroids and Rituximab in Bullous Pemphigoid: A Retrospective Cohort Studyjournal article10.1007/s40257-022-00688-x355798532-s2.0-85130462673WOS:000796784300001